IHT Wealth Management LLC boosted its position in shares of The Clorox Company (NYSE:CLX – Get Rating) by 23.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,362 shares of the company’s stock after purchasing an additional 1,033 shares during the period. IHT Wealth Management LLC’s holdings in Clorox were worth $688,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of CLX. Federated Hermes Inc. raised its stake in Clorox by 86.2% during the second quarter. Federated Hermes Inc. now owns 1,945,898 shares of the company’s stock worth $274,332,000 after purchasing an additional 901,040 shares during the period. State Street Corp raised its stake in shares of Clorox by 9.6% in the 2nd quarter. State Street Corp now owns 8,907,083 shares of the company’s stock valued at $1,255,721,000 after acquiring an additional 778,269 shares during the period. BlackRock Inc. raised its stake in shares of Clorox by 5.6% in the 3rd quarter. BlackRock Inc. now owns 10,964,049 shares of the company’s stock valued at $1,407,673,000 after acquiring an additional 580,982 shares during the period. Two Sigma Investments LP raised its stake in shares of Clorox by 4,186.6% in the 3rd quarter. Two Sigma Investments LP now owns 303,622 shares of the company’s stock valued at $38,982,000 after acquiring an additional 296,539 shares during the period. Finally, Invesco Ltd. raised its stake in shares of Clorox by 38.2% in the 1st quarter. Invesco Ltd. now owns 1,051,679 shares of the company’s stock valued at $146,216,000 after acquiring an additional 290,833 shares during the period. 79.12% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
CLX has been the topic of a number of research analyst reports. Barclays reduced their price target on shares of Clorox from $110.00 to $108.00 and set an “underweight” rating on the stock in a research note on Monday, February 6th. Jefferies Financial Group lifted their price objective on shares of Clorox from $140.00 to $145.00 and gave the company a “hold” rating in a report on Wednesday, February 1st. JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $126.00 to $135.00 and gave the company an “underweight” rating in a report on Friday, January 13th. Raymond James lifted their price objective on shares of Clorox from $160.00 to $165.00 and gave the company an “outperform” rating in a report on Friday, February 3rd. Finally, StockNews.com assumed coverage on shares of Clorox in a report on Thursday. They issued a “hold” rating for the company. Seven equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $141.33.
Clorox Trading Down 0.6 %
Clorox (NYSE:CLX – Get Rating) last issued its quarterly earnings data on Thursday, February 2nd. The company reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.66 by $0.32. The business had revenue of $1.72 billion during the quarter, compared to the consensus estimate of $1.66 billion. Clorox had a net margin of 6.16% and a return on equity of 89.97%. The company’s revenue was up 1.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.66 EPS. As a group, research analysts expect that The Clorox Company will post 4.23 EPS for the current fiscal year.
Clorox Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 12th. Stockholders of record on Wednesday, April 26th will be given a dividend of $1.18 per share. The ex-dividend date is Tuesday, April 25th. This represents a $4.72 annualized dividend and a dividend yield of 3.07%. Clorox’s dividend payout ratio is presently 134.86%.
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.